For pharmacists, from Drug Topics: News, features, and analysis for pharmacists about long-term-care guidelines and related subjects
October 8, 2009
By:Alaina Scott, Senior Editor
The FDA has announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies.
 |
September 24, 2009
By:Alaina Scott, Senior Editor
Controversy is in the mix after two mail-order prescription surveys with conflicting results were released within two days of each other.
|
September 18, 2009
By:Fred Gebhart, Contributing Editor
The Joint Commission is targeting patient safety failures with a new program that will directly affect pharmacy operations.
|
September 9, 2009
By:Alaina Scott, Senior Editor
GlaxoSmithKline has announced that the FDA's Vaccines and Related Biological Products Advisory Committee voted that clinical data support both the efficacy and safety of Cervarix, the company's candidate cervical cancer vaccine.
|
September 4, 2009
By:Mari Edlin, Maude L. Campbell, Clinical Managing Editor, Healthcare Central Content Group
The term "cardiometabolic disorders" (CMD) refers to a cluster of interrelated risk factors (hypertension, elevated fasting glucose, reduced high-density lipoprotein, elevated triglycerides, and abdominal obesity) that promote the development of atherosclerotic cardiovascular disease and type 2 diabetes. With an estimated 47 million Americans facing increased risk of heart disease because of these conditions, management of patients' CMD is a priority for pharmacists.
|
September 4, 2009
By:Alaina Scott, Senior Editor
Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report. Keep reading to find out more.
|
August 31, 2009
By:Fred Gebhart, Contributing Editor
Want to see fear on the face of a pharmacist? Ask for a quick dosage conversion for a 75-year-old woman with breast cancer who has become too weak to swallow MS Contin tablets and needs an oral liquid morphine. Keep reading to learn more about making conversions easier.
|
August 17, 2009
By:Alaina Scott, Senior Editor
The U.S. Food and Drug Administration published two rules recently to help clarify how very ill patients can obtain access to investigational drugs and biologics when they are not eligible to participate in a clinical trial and have no other satisfactory treatment options.
|
August 10, 2009
By:Mari Edlin
Commercial medication therapy management programs are gaining in strength and popularity for medical, financial, and practical reasons. In Minnesota, a pilot program for state employees was so successful that two years later it expanded into a program for all fully insured members. Another program is in use by Minnesota Medicaid and General Mills. And in North Carolina, the Asheville Project is still going strong.
|
| 
| Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
|
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION|
 | | | |
| Is knowledge of herbal supplements valuable to you in the practice of pharmacy? | | | No, not at all. | | 0% | | | Yes, somewhat. | | 30% | | | Definitely helpful. | | 52% | | | It comes up daily. | | 17% | |
| | | |
|
|
  Drug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.
Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.  | 
